<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AJOR</journal-id><journal-title-group><journal-title>American Journal of Operations Research</journal-title></journal-title-group><issn pub-type="epub">2160-8830</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ajor.2014.44024</article-id><article-id pub-id-type="publisher-id">AJOR-47706</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Development of a Six Sigma Infrastructure for Trabeculectomy Process
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>an</surname><given-names>Öztürker</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>İbrahim</surname><given-names>Şahbaz</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zeynep</surname><given-names>Karaarası Öztürker</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mehmet</surname><given-names>Tolga Taner</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Şükrü</surname><given-names>Bayraktar</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gamze</surname><given-names>Kağan</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Eye Clinic, Istanbul Education and Research Hospital, Istanbul, Turkey</addr-line></aff><aff id="aff6"><addr-line>Department of Occupational Health and Safety, üsküdar University, Istanbul, Turkey</addr-line></aff><aff id="aff5"><addr-line>Eye Clinic, Istanbul Surgery Hospital, Turkey</addr-line></aff><aff id="aff2"><addr-line>Department of Opticianry, üsküdar University, Istanbul, Turkey</addr-line></aff><aff id="aff1"><addr-line>Beyoglu Eye Clinic, Istanbul, Turkey</addr-line></aff><aff id="aff4"><addr-line>Department of Healthcare Management, üsküdar University, Istanbul, Turkey</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>mehmettolga.taner@uskudar.edu.tr(MTT)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>07</month><year>2014</year></pub-date><volume>04</volume><issue>04</issue><fpage>246</fpage><lpage>254</lpage><history><date date-type="received"><day>28</day>	<month>May</month>	<year>2014</year></date><date date-type="rev-recd"><day>1</day>	<month>July</month>	<year>2014</year>	</date><date date-type="accepted"><day>8</day>	<month>July</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The aim of this article is to show how an eye clinic of a Turkish public hospital initiated Six Sigma principles to reduce the number of complications encountered during and after trabeculectomy surgeries. Data were collected for ten years. To analyse the process, main tools of Six Sigma’s Define-Measure-Analyze-Improve-Control (DMAIC) improvement cycle such as SIPOC Table, Failure, Mode and Effect Analysis were implemented. Sources and root causes of ten types of complications were identified and reported. Patient’s eye anatomy, experience of ophthalmic surgeon, quality of surgical equipment, quality and type of suture, and experience of staff were identified to be Critical-to-Quality (CTQ) factors for a successful surgery. The most frequently occurring complication was found to be hypotony. The process sigma level of the process was measured to be 3.1391. The surgical team concluded that ten complications (out of twelve) should be significantly reduced by taking the necessary preventative measures.
 
</p></abstract><kwd-group><kwd>Six Sigma</kwd><kwd> Ophthalmology</kwd><kwd> Trabeculectomy</kwd><kwd> Complications</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Glaucoma is one of the leading causes of irreversible blindness throughout the world. World Health Organiza- tion (WHO) has stated that glaucoma accounts for blindness in 5.1 million people or 13.5% of the global blind- ness, i.e. behind cataracts and trachoma at 15.8 million and 5.9 million persons, or 41.8% and 15.5% of global blindness, respectively [<xref ref-type="bibr" rid="scirp.47706-ref1">1</xref>] . Glaucoma has become the second most common cause of bilateral blindness world- wide. In the US, it is the second leading cause of blindness and the most frequent cause of blindness (5.6%) among African-Americans, according to the US Department of Commerce’s Bureau of the Census 1990 pro- vided by the National Society to prevent blindness in 1993 [<xref ref-type="bibr" rid="scirp.47706-ref1">1</xref>] . Even though it is known to be more commonly afflicting older adults, it may occur in all segments of society with significant health and economic consequences, making it a major health problem [<xref ref-type="bibr" rid="scirp.47706-ref2">2</xref>] .</p><p>Trabeculectomy, the most commonly performed glaucoma filtering procedure, is performed when medical treatment or laser therapy or both fails to reduce IOP from a level that has been associated with progressive vis- ual filed loss or optic nerve damage. It is indicated when target intraocular pressure (IOP) is not achieved or when the neural tissue or visual function is progressively lost despite maximally tolerated medical or laser ther- apies. The filtering surgery is performed at the surgical limbus where the peripheral cornea meets the sclera ex- ternally. Ineffectiveness, intolerance, and poor compliance with medical therapy yield the decision for surgical intervention [<xref ref-type="bibr" rid="scirp.47706-ref3">3</xref>] .</p><p>Trabeculectomy is performed as an ambulatory procedure unless general medical care requires medical ad- mission [<xref ref-type="bibr" rid="scirp.47706-ref4">4</xref>] . The purpose of the treatment is to maintain visual function and prevent further loss. Although many factors may contribute to glaucomatous optic neuropathy, reduction of IOP remains the primary therapeutic goal. Medical treatment and laser or incisional surgery to lower IOP prevents additional visual field loss in most pa- tients with primary open-angle glaucoma [<xref ref-type="bibr" rid="scirp.47706-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.47706-ref6">6</xref>] .</p><p>Although glaucoma filtering surgery risks are usually limited to those of local anesthetics and ocular compli- cations, knowledge of general medical conditions such as diabetes, hypertension, cardiac status, and anticoagu- lant use, is important [<xref ref-type="bibr" rid="scirp.47706-ref4">4</xref>] .</p><p>Intraoperative complications may be related to anesthesia, corneal traction suture, conjunctiva and scleral flap [<xref ref-type="bibr" rid="scirp.47706-ref4">4</xref>] . Many postoperative complications such as hypotony and shallow anterior chamber also occur as a direct re- sult of poor surgical technique involving scleral flap dissection, inner block removal or conjunctival closure [<xref ref-type="bibr" rid="scirp.47706-ref4">4</xref>] . However, complications are not limited to the immediate postoperative period. Longterm changes in the bleb may predispose to leaks, blebitis and endophtalmitis [<xref ref-type="bibr" rid="scirp.47706-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.47706-ref11">11</xref>] . To minimize complications and enhance surgical success, attention should be paid to each step of the procedure. Therefore, complications must be detected early in order to initiate adequate preventative and therapeutic measures.</p><p>Once the blindness of glaucoma has occurred, there is no known treatment that will restore the lost vision. In nearly all cases, however, blindness from glaucoma is preventable [<xref ref-type="bibr" rid="scirp.47706-ref12">12</xref>] . This prevention requires early detection and proper treatment. Detection depends on the ability to recognize the early clinical manifestations of the vari- ous glaucoma types [<xref ref-type="bibr" rid="scirp.47706-ref12">12</xref>] . Approporiate treatment requires an understanding of the pathogenic mechanisms in- volved, as well as a detailed knowledge of the drugs and operations that are used to control the IOP [<xref ref-type="bibr" rid="scirp.47706-ref12">12</xref>] . Thus, postoperative trabeculectomy care is as important as the procedure itself in determining the outcome. Anterior chamber depth, IOP level and bleb characteristics are important determinants of aqueous humor outflow through the fistula. Modulation of the postoperative inflammation and wound healing process may also affect the success [<xref ref-type="bibr" rid="scirp.47706-ref13">13</xref>] .</p><p>The use of Six Sigma, as a quality improvement method, can be employed in order to eliminate complications encountered during and after ophthalmic surgeries [<xref ref-type="bibr" rid="scirp.47706-ref14">14</xref>] . Originally initiated by Motorola, Honeywell and Gener- al Electric [<xref ref-type="bibr" rid="scirp.47706-ref15">15</xref>] , Six Sigma is a powerful performance improvement tool that is changing the face of modern healthcare delivery [<xref ref-type="bibr" rid="scirp.47706-ref16">16</xref>] . Although it was initially introduced in manufacturing processes, it is being imple- mented in diagnostic imaging processes [<xref ref-type="bibr" rid="scirp.47706-ref17">17</xref>] - [<xref ref-type="bibr" rid="scirp.47706-ref19">19</xref>] , emergency room [<xref ref-type="bibr" rid="scirp.47706-ref20">20</xref>] , paramedic backup [<xref ref-type="bibr" rid="scirp.47706-ref21">21</xref>] , laboratory [<xref ref-type="bibr" rid="scirp.47706-ref22">22</xref>] , cataract surgery [<xref ref-type="bibr" rid="scirp.47706-ref14">14</xref>] , radiology [<xref ref-type="bibr" rid="scirp.47706-ref23">23</xref>] , surgical site infections [<xref ref-type="bibr" rid="scirp.47706-ref24">24</xref>] , Intra Lase surgery [<xref ref-type="bibr" rid="scirp.47706-ref25">25</xref>] , LASIK surgery [<xref ref-type="bibr" rid="scirp.47706-ref26">26</xref>] , strabismus surgery [<xref ref-type="bibr" rid="scirp.47706-ref27">27</xref>] , intravitreal injections [<xref ref-type="bibr" rid="scirp.47706-ref28">28</xref>] , cataract surgery in patients with pseudoexfoliation syndrome [<xref ref-type="bibr" rid="scirp.47706-ref29">29</xref>] , pars plana vitrectomy [<xref ref-type="bibr" rid="scirp.47706-ref30">30</xref>] phacoemulsification cataract surgery [<xref ref-type="bibr" rid="scirp.47706-ref31">31</xref>] , and stent placement [<xref ref-type="bibr" rid="scirp.47706-ref32">32</xref>] as a cost-effective way to improve quality, performance and productivity.</p><p>A Six Sigma process produces 3.4 defective parts per million opportunities (DPMO) [<xref ref-type="bibr" rid="scirp.47706-ref33">33</xref>] . Being a method that eliminates errors, Six Sigma makes use of a structured methodology called DMAIC to find the main causes behind problems and to reach near perfect processes [<xref ref-type="bibr" rid="scirp.47706-ref34">34</xref>] . DMAIC is useful to analyse and modify complicated time-sensitive healthcare processes involving multiple specialists and treatment areas by identifying and remov- ing root causes of errors or complications and thus minimizing healthcare process variability [<xref ref-type="bibr" rid="scirp.47706-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.47706-ref33">33</xref>] .</p><p>In this study, a Six Sigma infrastructure was developed for a public eye care centre in order to reduce the number of complications and thus, improve the outcomes of their trabeculectomy surgeries. In addition, sigma level of each type of complication are calculated and reported.</p></sec><sec id="s2"><title>2. Method: Application of Six Sigma’s DMAIC for Trabeculectomy Surgery</title><p>When the eye care centre decided that Six Sigma was the best way to achieve their goals, a surgical team was assembled and trained in the methodology. Committed and consistent leadership to overcome the complications was assured by this team. They firstly generated a SIPOC (Supplier, Input, Process, Output and Customer) <xref ref-type="table" rid="table">Table </xref>for the process (<xref ref-type="table" rid="table">Table </xref>1). To achieve the performance objective, the surgical team first determined by brains- torming the CTQ factors, i.e. the factors that may have an influence on the objective.</p><p>The surgical team determined the metrics to measure existing process. The metrics to be chosen for a Six Sigma study were:</p><p>1) Total number of surgeries performed in the eye care centre,</p><p>2) Number of complications.</p><p>Data were collected for a period of ten years. In this period, surgeries were performed on 253 eyes. Complica- tions experienced (<xref ref-type="table" rid="table">Table </xref>2) had been noted as they occurred. The surgical team identified ten types of complica- tions and classified them as when (i.e. intraoperatively and/or postoperatively), and how soon they occur, i.e. acute, sub-acute and/or chronic (<xref ref-type="table" rid="table">Table </xref>4). Then, sources (<xref ref-type="table" rid="table">Table </xref>3) and root-causes (<xref ref-type="table" rid="table">Table </xref>4) of these complica- tions are tabulated by type.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table">Table </xref>1</label><caption><title> SIPOC table for trabeculectomy surgery</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Supplier</th><th align="center" valign="middle" >Input</th><th align="center" valign="middle" >Process</th><th align="center" valign="middle" >Output</th><th align="center" valign="middle" >Customer</th></tr></thead><tr><td align="center" valign="middle" >Ophthalmic surgeon</td><td align="center" valign="middle" >Patient</td><td align="center" valign="middle" >General and preoperative evaluation</td><td align="center" valign="middle" >IOP under control</td><td align="center" valign="middle" >Patient</td></tr><tr><td align="center" valign="middle" >Assistant surgeon</td><td align="center" valign="middle" >Microscope</td><td align="center" valign="middle" >Preoperative regulation of sistemic body health</td><td align="center" valign="middle" >Long-term survival of the optic nerve</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Nurse</td><td align="center" valign="middle" >Surgical equipment</td><td align="center" valign="middle" >Preparation of conjunctival and scleral flap</td><td align="center" valign="middle" >Preservation of visual acuity</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Anaesthesia doctor</td><td align="center" valign="middle" >Light</td><td align="center" valign="middle" >Trabeculectomy</td><td align="center" valign="middle" >Preservation of visual field</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Suture material</td><td align="center" valign="middle" >Suturation of scleral flap and conjunctiva</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Discharge</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table">Table </xref>2</label><caption><title> Complications experienced</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Complication</th><th align="center" valign="middle" >Intra-Operative</th><th align="center" valign="middle" >Post-Operative</th><th align="center" valign="middle" >Acute</th><th align="center" valign="middle" >Sub-Acute</th><th align="center" valign="middle" >Chronic</th></tr></thead><tr><td align="center" valign="middle" >Type I</td><td align="center" valign="middle" >Conjunctival incontinence and perforation (defect)</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type II</td><td align="center" valign="middle" >Expulsive haemorrhage</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type III</td><td align="center" valign="middle" >Hypotony</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type IV</td><td align="center" valign="middle" >Shallow anterior chamber</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type V</td><td align="center" valign="middle" >Hyphema</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type VI</td><td align="center" valign="middle" >Fibrin reaction</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type VII</td><td align="center" valign="middle" >Choroidal detachment</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type VIII</td><td align="center" valign="middle" >Chronic hypotony and maculopathy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type IX</td><td align="center" valign="middle" >Positive seidel test</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type X</td><td align="center" valign="middle" >Early cataract formation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type XI</td><td align="center" valign="middle" >Malignant glaucoma</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type XII</td><td align="center" valign="middle" >Retinal detachment</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table">Table </xref>3</label><caption><title> Sources of complications</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Surgeon</th><th align="center" valign="middle" >Staff</th><th align="center" valign="middle" >Patient</th><th align="center" valign="middle" >Equipment</th><th align="center" valign="middle" >Suture Material</th></tr></thead><tr><td align="center" valign="middle" >Type I</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type II</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type III</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type IV</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type V</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type VI</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type VII</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type VIII</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type IX</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type XI</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type XII</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table">Table </xref>4</label><caption><title> Root-causes of complications</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Experience of Surgeon</th><th align="center" valign="middle" >Experience of Staff</th><th align="center" valign="middle" >Patient’s Eye Anotomy</th><th align="center" valign="middle" >Quality of Surgical Equipment</th><th align="center" valign="middle" >Quality and Type of Suture</th></tr></thead><tr><td align="center" valign="middle" >Type I</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type II</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type III</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type IV</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type V</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type VI</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type VII</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type VIII</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type IX</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" >X</td></tr><tr><td align="center" valign="middle" >Type X</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type XI</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type XII</td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >X</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></sec><sec id="s3"><title>3. Analysis</title><p>The surgical team analysed the occurrence frequency of each complication and related them with the root-causes. (<xref ref-type="table" rid="table">Table </xref>4 and <xref ref-type="table" rid="table">Table </xref>5). The analysis revealed that hyptony (Type III), shallow anterior chamber (Type IV) and hyphema (Type V) were the three most frequently occurring complications in the trabeculectomy surgeries (Ta- ble 5). Then, they classified the CTQs as “vital few factors” and “trivial many factors” according to how fre- quent they caused the complications. The “vital few” factors, i.e. the factors that had the most impact on the success of surgery were determined to be the patient’s eye anatomy and ophthalmic surgeon’s experience. The other factors, i.e. quality of the surgical equipment, quality and type of suture, and experience of staff were the “trivial many”.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table">Table </xref>5</label><caption><title> Frequencies, DPMOs and sigma levels</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Count</th><th align="center" valign="middle" >Frequency (%)</th><th align="center" valign="middle" >DPMO</th><th align="center" valign="middle" >Sigma Level</th></tr></thead><tr><td align="center" valign="middle" >Type I</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1.97</td><td align="center" valign="middle" >19,763</td><td align="center" valign="middle" >3.56</td></tr><tr><td align="center" valign="middle" >Type II</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.39</td><td align="center" valign="middle" >3953</td><td align="center" valign="middle" >4.16</td></tr><tr><td align="center" valign="middle" >Type III</td><td align="center" valign="middle" >113</td><td align="center" valign="middle" >44.66</td><td align="center" valign="middle" >446,640</td><td align="center" valign="middle" >1.63</td></tr><tr><td align="center" valign="middle" >Type IV</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >29.64</td><td align="center" valign="middle" >296,443</td><td align="center" valign="middle" >2.03</td></tr><tr><td align="center" valign="middle" >Type V</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >19.36</td><td align="center" valign="middle" >193,676</td><td align="center" valign="middle" >2.36</td></tr><tr><td align="center" valign="middle" >Type VI</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >12.64</td><td align="center" valign="middle" >126,482</td><td align="center" valign="middle" >2.64</td></tr><tr><td align="center" valign="middle" >Type VII</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >10.67</td><td align="center" valign="middle" >106,719</td><td align="center" valign="middle" >2.74</td></tr><tr><td align="center" valign="middle" >Type VIII</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >3.16</td><td align="center" valign="middle" >31,621</td><td align="center" valign="middle" >3.36</td></tr><tr><td align="center" valign="middle" >Type IX</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >3.16</td><td align="center" valign="middle" >31,621</td><td align="center" valign="middle" >3.36</td></tr><tr><td align="center" valign="middle" >Type X</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.18</td><td align="center" valign="middle" >11,858</td><td align="center" valign="middle" >3.76</td></tr><tr><td align="center" valign="middle" >Type XI</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.79</td><td align="center" valign="middle" >7905</td><td align="center" valign="middle" >3.91</td></tr><tr><td align="center" valign="middle" >Type XII</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.39</td><td align="center" valign="middle" >3953</td><td align="center" valign="middle" >4.16</td></tr></tbody></table></table-wrap><p>To measure the current sigma level of a complication, surgical team calculated the current DPMO and sigma levels for each complication type (<xref ref-type="table" rid="table">Table </xref>5). For this, two distinct datasets are required: total number of trabecu- lectomy surgeries performed (A) and total number of complications occurred (B). Then, the DPMO can be cal- culated from Equation (1) as follows:</p><disp-formula id="scirp.47706-formula655"><label>(1)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/7-1040328x6.png"  xlink:type="simple"/></disp-formula><p>Normal distribution underlies Six Sigma’s statistical assumptions [<xref ref-type="bibr" rid="scirp.47706-ref14">14</xref>] . An empirically-based 1.5 sigma shift is introduced into the calculation. A higher sigma level indicates a lower rate of complications and a more efficient process [<xref ref-type="bibr" rid="scirp.47706-ref14">14</xref>] .</p><p>The highest sigma level was obtained for expulsive haemorrhage (Type II) and retinal detachment (Type XII). The lowest sigma level was found to belong to hypotony (Type III). Having sigma levels lower than 4.00; all types of complications except haemorrhage (Type II) and retinal detachment (Type XII) needed to be signifi- cantly reduced.</p><p>The process sigma level, calculated from the arithmetic average of sigma levels of twelve complications, was found to be 3.1391.</p></sec><sec id="s4"><title>4. Discussion</title><p>Risk assessment of the surgery was achieved by the Failure Mode and Effect Analysis (FMEA). Utilization of the FMEA involved break down the process into individual steps: potential failure modes (i.e. complications), severity score, probability score, hazard score, criticality and detection, so that the surgery team could look at key drivers in the process based on the past experience.</p><p>Occurrence trends and consequences of complications over a 10-year period had been monitored and recorded. Surgical team prioritized the complications according to how serious their consequences were (i.e. severity score); how frequently they occurred (i.e. probability score) and how easily they could be detected. Hazard analysis was employed in order to identify failure modes and their causes and effects. The surgery team deter- mined the severity of each complication and assigned scores for them. The severity of each complication was scored from 1 to 4 (<xref ref-type="table" rid="table">Table </xref>6).</p><p>For each complication type, the hazard score was calculated by multiplying the severity score with the proba- bility score. Consequently, an FMEA table was drawn (<xref ref-type="table" rid="table">Table </xref>7). Among the complications, hypotony (Type III) yielded the highest hazard score. Haemorrhage (Type II) and retinal detachment (Type XII) were almost equally hazardous complications. According to FMEA, both were the least hazardous complications.</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table">Table </xref>6</label><caption><title> Severity scores</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Severity Score</th><th align="center" valign="middle" >4</th><th align="center" valign="middle" >3</th><th align="center" valign="middle" >2</th><th align="center" valign="middle" >1</th></tr></thead><tr><td align="center" valign="middle" >Severity of Complication</td><td align="center" valign="middle" >Permanent harm</td><td align="center" valign="middle" >Temporary harm</td><td align="center" valign="middle" >Bias</td><td align="center" valign="middle" >No harm</td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table">Table </xref>7</label><caption><title> FMEA table</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Complication Type</th><th align="center" valign="middle"  colspan="3"  >Hazard Analysis</th><th align="center" valign="middle"  colspan="2"  >Decision Tree Analysis</th></tr></thead><tr><td align="center" valign="middle" >Severity Score</td><td align="center" valign="middle" >Probability Score</td><td align="center" valign="middle" >Hazard Score</td><td align="center" valign="middle" >Critical?</td><td align="center" valign="middle" >Detectable?</td></tr><tr><td align="center" valign="middle" >Type I</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.0197</td><td align="center" valign="middle" >0.0394</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td></tr><tr><td align="center" valign="middle" >Type II</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0039</td><td align="center" valign="middle" >0.0156</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Type III</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.4466</td><td align="center" valign="middle" >1.3398</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td></tr><tr><td align="center" valign="middle" >Type IV</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.2964</td><td align="center" valign="middle" >0.8892</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td></tr><tr><td align="center" valign="middle" >Type V</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.1936</td><td align="center" valign="middle" >0.3872</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td></tr><tr><td align="center" valign="middle" >Type VI</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.1264</td><td align="center" valign="middle" >0.2528</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td></tr><tr><td align="center" valign="middle" >Type VII</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.1067</td><td align="center" valign="middle" >0.3201</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Type VIII</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0316</td><td align="center" valign="middle" >0.1264</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Type IX</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.0316</td><td align="center" valign="middle" >0.0948</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >Yes</td></tr><tr><td align="center" valign="middle" >Type X</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.0118</td><td align="center" valign="middle" >0.0354</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >Yes</td></tr><tr><td align="center" valign="middle" >Type XI</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0079</td><td align="center" valign="middle" >0.0316</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Type XII</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0039</td><td align="center" valign="middle" >0.0156</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr></tbody></table></table-wrap>Corrective Action Plan<p>The surgical team developed preventive measures for each type of complication in order to bring the overall surgery process under control (See the Appendix). By brainstorming on the mechanisms underlying the compli- cations, they implemented the following corrective action plan to reduce and/or eliminate other complications.</p></sec><sec id="s5"><title>5. Conclusions</title><p>In this study, authors found that twelve types of complications were encountered in the eye care centre while performing trabeculectomy surgeries. The analysis showed that these complications had occurred either intra- operatively or postoperatively. Postoperative complications were almost always related to the events that had occurred during the surgery. The process sigma level of the overall process (i.e. trabeculectomy surgeries per- formed in 10-years) was measured to be 3.1391.</p><p>It was found that patient’s eye anatomy and surgeon’s experience were the vital few CTQ factors that had the most impact on the success of surgeries. Many complications were related to the learning curve associated with the technique used in the procedure. These complication rates were reduced as surgeons gained experience and were trained on how to identify, minimize or eliminate the sources and root-causes of the complications. These lections of quality and type of suture are also essential. Staff should be trained to gain more experience on the surgery.</p><p>To conclude, the risks associated with trabeculectomy can be minimized by taking the necessary preventative measures with appropriate preoperative, intraoperative and postoperative care.</p></sec><sec id="s6"><title>Cite this paper</title><p>Can&#214;zt&#252;rker,İbrahimŞahbaz,Zeynep Karaarası&#214;zt&#252;rker,Mehmet TolgaTaner,Ş&#252;kr&#252;Bayraktar,GamzeKağan, (2014) Development of a Six Sigma Infrastructure for Trabeculectomy Process. American Journal of Operations Research,04,246-254. doi: 10.4236/ajor.2014.44024</p></sec><sec id="s7"><title>Appendix</title></sec><sec id="s8"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.47706-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Hairston, R.J., Maguire, A.M., Vitale, S. and Green, W.R. (1996) Morphometric Analysis of Pars Plana Development in Humans. Retina (Philadelphia, Pa.), 17, 135-138. http://dx.doi.org/10.1097/00006982-199703000-00009</mixed-citation></ref><ref id="scirp.47706-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leske</surname><given-names> M.C. </given-names></name>,<etal>et al</etal>. (<year>1983</year>)<article-title>The Epidemiology of Open-Angle Glaucoma: A Review</article-title><source> American Journal of Epidemiology</source><volume> 118</volume>,<fpage> 166</fpage>-<lpage>191</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47706-ref3"><label>3</label><mixed-citation publication-type="book" xlink:type="simple">Katz, L.J., Costa, V.P. and Spaeth, G.L. (1996) Filtration Surgery, Chapter 83, Glaucoma Surgery, Part 7, Glaucoma Therapy, Volume 3, The Glaucomas. In: Ritch, R., Shields, M.B. and Krupin, T., Eds., 2nd Edition, Mosby-Yearbook Inc., St. Louis, 1661-1702.</mixed-citation></ref><ref id="scirp.47706-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Lerner, S.F. and Parrish II, R.K. (2003) Glaucoma Surgery. Lippincott Williams and Wilkins, USA.</mixed-citation></ref><ref id="scirp.47706-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Sherwood, M.B., Migdal, C.S. and Hitchings, R.A. (1993) Initial Treatment of Glaucoma: Surgery or Medications: I. Initial Treatment of Glaucoma: Filtration Surgery. Survey of Ophthalmology, 37, 293-299.http://dx.doi.org/10.1016/0039-6257(93)90013-W</mixed-citation></ref><ref id="scirp.47706-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lichter, P.R., Musch, D.C., Gillespie, B.W., Guire, K.E., Janz, N.K., Wren, P.A. and Mills, M.P.H. (2001) Interim Clinical Outcomes in the Collaborative Initial Glaucoma Treatment Study Comparing Initial Treatment Randomized to Medications or Surgery. Ophthalmology, 108, 1943-1953. http://dx.doi.org/10.1016/S0161-6420(01)00873-9</mixed-citation></ref><ref id="scirp.47706-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Jampel, H.D., Quigley, H.A., Kerrigan-Baumrind, L.A., Melia, B.M., Friedman, D. and Barron, Y. (2001) Risk Factors for Late-Onset Infection Following Glaucoma Filtration Surgery. Archives of Ophthalmology, 119, 1001-1008.http://dx.doi.org/10.1001/archopht.119.7.1001</mixed-citation></ref><ref id="scirp.47706-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Chen, P.P., Gedde, S.J., Budenz, D.L. and Parrish, R.K. (1997) Outpatient Treatment of Bleb Infection. Archives of Ophthalmology, 115, 1124-1128. http://dx.doi.org/10.1001/archopht.1997.01100160294005</mixed-citation></ref><ref id="scirp.47706-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ciulla, T.A., Beck, A.D., Topping, T.M. and Baker, A.S. (1997) Blebitis, Early Endophthalmitis, and Late Endophthalmitis after Glaucoma-Filtering Surgery. Ophthalmology, 104, 986-995.http://dx.doi.org/10.1016/S0161-6420(97)30196-1</mixed-citation></ref><ref id="scirp.47706-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">DeBry, P.W., Perkins, T.W., Heatley, G., Kaufman, P. and Brumback, L.C. (2002) Incidence of Late-Onset BlebRelated Complications Following Trabeculectomy with Mitomycin. Archives of Ophthalmology, 120, 297-300.http://dx.doi.org/10.1001/archopht.120.3.297</mixed-citation></ref><ref id="scirp.47706-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kangas, T.A., Greenfield, D.S., Flynn Jr., H.W., Parrish II, R.K. and Palmberg, P. (1997) Delayed-Onset Endophthalmitis Associated with Conjunctival Filtering Blebs. Ophthalmology, 104, 746-752.http://dx.doi.org/10.1016/S0161-6420(97)30238-3</mixed-citation></ref><ref id="scirp.47706-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Allingham, R.R., Damji, K.F., Freedman, S., Moroi, S.E. and Shafranov, G. (2005) Shields’ Textbook of Glaucoma. 5th Edition, Lippincott Williams and Wilkins, USA.</mixed-citation></ref><ref id="scirp.47706-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Roth, S.M., Spaeth, G.L., Starita, R.J., Birbillis, E.M. and Steinmann, W.C. (1991) The Effects of Postoperative Corticosteroids on Trabeculectomy and the Clinical Course of Glaucoma: Five-Year Follow-Up Study. Ophthalmic Surgery, 22, 724-729.</mixed-citation></ref><ref id="scirp.47706-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Taner, M.T. (2013) Application of Six Sigma Methodology to a Cataract Surgery Unit. International Journal of Health Care Quality Assurance, 26, 768-785. http://dx.doi.org/10.1108/IJHCQA-02-2012-0022</mixed-citation></ref><ref id="scirp.47706-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mehrjerdi, Y.Z. (2011) Six Sigma: Methodology, Tools and Its Future. International Journal of Assembly Automation, 31, 79-88. http://dx.doi.org/10.1108/01445151111104209</mixed-citation></ref><ref id="scirp.47706-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Taner, M.T., Sezen, B. and Antony, J. (2007) An Overview of Six Sigma Applications in Healthcare Industry. International Journal of Health Care Quality Assurance, 20, 329-340. http://dx.doi.org/10.1108/09526860710754398</mixed-citation></ref><ref id="scirp.47706-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Antony, J. and Banuelas, R. (2002) Key Ingredients for the Effective Implementation of Six Sigma Program. Measuring Business Excellence, 6, 20-27. http://dx.doi.org/10.1108/13683040210451679</mixed-citation></ref><ref id="scirp.47706-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Antony, J., Antony, F.J., Kumar, M. and Cho, B.R. (2007) Six Sigma in Service Organisations: Benefits, Challenges and Difficulties, Common Myths, Empirical Observations and Success Factors. In-ternational Journal of Quality and Reliability Management, 24, 294-311. http://dx.doi.org/10.1108/02656710710730889</mixed-citation></ref><ref id="scirp.47706-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Taner, M.T., Sezen, B. and Atwat, K.M. (2012) Application of Six Sigma Methodology to a Diagnostic Imaging Process. International Journal of Health Care Quality Assurance, 25, 274-290.http://dx.doi.org/10.1108/09526861211221482</mixed-citation></ref><ref id="scirp.47706-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Miller, M.J., Ferrin, D.M. and Szymanski, J.M. (2003) Simulating Six Sigma Improvement Ideas for a Hospital Emergency Department. Proceedings of the IEEE Winter Simulation Conference, New Orleans, 7-10 December 2003, 1926-1929.</mixed-citation></ref><ref id="scirp.47706-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Taner, M.T. and Sezen, B. (2009) An Application of Six Sigma Methodology to Turnover Intentions in Healthcare. International Journal of Health Care Quality Assurance, 22, 252-265. http://dx.doi.org/10.1108/09526860910953520</mixed-citation></ref><ref id="scirp.47706-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Nevalainen, D., Berte, L., Kraft, C., Leigh, E., Picaso, L. and Morgan, T. (2000) Evaluating Laboratory Performance on Quality Indicators with the Six Sigma Scale. Archives of Pathology and Laboratory Medicine, 124, 516-519.</mixed-citation></ref><ref id="scirp.47706-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Cherry, J. and Seshadri, S. (2000) Six Sigma: Using Statistics to Reduce Process Variability and Costs in Radiology. Radiology Management, 22, 42-49.</mixed-citation></ref><ref id="scirp.47706-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Pexton, C. and Young, D. (2004) Reducing Surgical Site Infections through Six Sigma and Change Management. Patient Safety and Quality Healthcare, 1, 1-8.</mixed-citation></ref><ref id="scirp.47706-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Sahbaz, I., Taner, M.T., Eliacik, M., Kagan, G. and Erbas, E. (2014) Adoption of Six Sigma’s DMAIC to Reduce Complications in IntraLase Surgeries. International Journal of Statistics in Medical Research, 3, 126-133.http://dx.doi.org/10.6000/1929-6029.2014.03.02.6</mixed-citation></ref><ref id="scirp.47706-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Taner, M.T., Kagan, G., Sahbaz, I., Erbas, E. and Kagan, S.B. (2014) A Preliminary Study for Six Sigma Implementation in Laser in Situ Keratomileusis (LASIK) Surgeries. International Review of Management and Marketing, 4, 24-33.</mixed-citation></ref><ref id="scirp.47706-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Taner, M.T., Sahbaz, I., Kagan, G., Atwat, K. and Erbas, E. (2014) Development of Six Sigma Infrastructure for Strabismus Surgeries. International Review of Management and Marketing, 4, 49-58.</mixed-citation></ref><ref id="scirp.47706-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Sahbaz, I., Taner, M.T., Eliacik, M., Kagan, G., Erbas, E. and Enginyurt, H. (2014) Deployment of Six Sigma Methodology to Reduce Complications in Intravitreal Injections. International Review of Management and Marketing, 4, 160-166.</mixed-citation></ref><ref id="scirp.47706-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Sahbaz, I., Taner, M.T., Kagan, G., Sanisoglu, H., Durmus, E., Tunca, M., Erbas, E., Kagan, S.B., Kagan, M.K. and Enginyurt, H. (2014) Development of a Six Sigma Infrastructure for Cataract Surgery in Patients with Pseudoexfoliation Syndrome. Archives of Business Research, 2, 15-23. http://dx.doi.org/10.14738/abr.22.173</mixed-citation></ref><ref id="scirp.47706-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Sahbaz, I., Taner, M.T., Sanisoglu, H., Kar, T., Kagan, G., Durmus, E., Tunca, M., Erbas, E., Armagan, I. and Kagan, M.K. (2014) Deployment of Six Sigma Methodology to Pars Plana Vitrectomy. International Journal of Statistics in Medical Research, 3, 94-102. http://dx.doi.org/10.6000/1929-6029.2014.03.02.3</mixed-citation></ref><ref id="scirp.47706-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Sahbaz, I., Taner, M.T., Kagan, G., Sanisoglu, H., Erbas, E., Durmus, E., Tunca, M. and Enginyurt, H. (2014) Deployment of Six Sigma Methodology in Phacoemulsification Cataract Surgeries. International Review of Management and Marketing, 4, 123-131.</mixed-citation></ref><ref id="scirp.47706-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Taner, M.T., Kagan, G., Celik, S., Erbas, E. and Kagan, M.K. (2013) Formation of Six Sigma Infrastructure for the Coronary Stenting Process. International Review of Management and Marketing, 3, 232-242.</mixed-citation></ref><ref id="scirp.47706-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Buck, C. (2001) Application of Six Sigma to Reduce Medical Errors. Annual Quality Congress Proceedings, Charlotte, 11-15 April 2001, 739-742.</mixed-citation></ref><ref id="scirp.47706-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Park, S.H. and Antony, J. (2008) Robust Design for Quality Engineering and Six Sigma. World Scientific Publishing, New Jersey. http://dx.doi.org/10.1142/6655</mixed-citation></ref></ref-list></back></article>